Hahn: FDA won’t make regulatory decisions based on preprints or news releases

The COVID-19 pandemic has upended the long standing model for publishing clinical data as researchers and drugmakers race to share the latest findings about treatment and vaccine candidates at a time when case counts and deaths are still rising.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.